Torthaí cuardaigh - Norman C. W. Wong

  • 1 - 3 toradh as 3 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Íomhá chlúdaigh

    Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy de réir Li Fu, Sylwia Wasiak, Laura M. Tsujikawa, Brooke D. Rakai, Stephanie C. Stotz, Norman C. W. Wong, Jan O. Johansson, Michael Sweeney, Connie M. Mohan, Aneal Khan, Ewelina Kulikowski

    Foilsithe / Cruthaithe 2022
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Íomhá chlúdaigh

    Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease de réir Sylwia Wasiak, Dean Gilham, Emily Daze, Laura M. Tsujikawa, Christopher Halliday, Stephanie C. Stotz, Brooke D. Rakai, Li Fu, Ravi Jahagirdar, Michael Sweeney, Jan O. Johansson, Norman C. W. Wong, Ewelina Kulikowski

    Foilsithe / Cruthaithe 2020
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Íomhá chlúdaigh

    Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and modera... de réir Peter P. Toth, Gregory G. Schwartz, Stephen J. Nicholls, Aziz Khan, Michael Szarek, Henry N. Ginsberg, Jan O. Johansson, Kamyar Kalantar-Zadeh, Ewelina Kulikowski, Ken Lebioda, Norman C.W. Wong, Michael Sweeney, Kausik K. Ray

    Foilsithe / Cruthaithe 2022
    Connect to this object online.
    LEABHAR

    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: